ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 801–900 of 1,001
Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
Jacquelot, N., Ghaedi, M., Warner, K., Chung, D. C., Crome, S. Q., & Ohashi, P. S. (2021) · Cancers · doi:10.3390/cancers13235967 · Cited by 23
Brandi, J., Wiethe, C., Riehn, M., & Jacobs, T. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24740 · Cited by 23
“Inducible T cell co-stimulator (ICOS, CD278) is a co-stimulatory molecule that is upregulated upon T cell activation and enhances T cell responses in a similar manner to CD28 [38], though its contribution in the immune response appears to vary in different disease models [39].”
BackgroundAP ‐1 is involved in ICOS gene expression downstream of TCR / CD 28 and cytokine receptor signaling
Watanabe, M., Nakajima, S., Ohnuki, K., Ogawa, S., Yamashita, M., Nakayama, T., Murakami, Y., Tanabe, K., & Abe, R. (2012) · European Journal of Immunology · doi:10.1002/eji.201141897 · Cited by 23
Altered T cell costimulation during chronic hepatitis B infection
Barboza, L., Salmen, S., Peterson, D. L., Montes, H., Colmenares, M. C., Hernández, M. H., Berrueta-Carrillo, L., & Berrueta, L. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.02.008 · Cited by 22
Expansion of Circulating T Follicular Helper Cells in Children with Acute Henoch-Schönlein Purpura
Xie, J., Liu, Y., Wang, L., Ruan, G., Yuan, H., Fang, H., Wu, J., & Cui, D. (2015) · Journal of Immunology Research · doi:10.1155/2015/742535 · Cited by 22
Odobasic, D., Kitching, A. R., Semple, T. J., & Holdsworth, S. R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101022 · Cited by 22
The role of B cells in animal models of rheumatoid arthritis
Shannon, K. O. (2006) · Frontiers in bioscience · doi:10.2741/2184 · Cited by 23
Loke, P., Zang, X., Hsuan, L., Waitz, R., Locksley, R. M., Allen, J. E., & Allison, J. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503961102 · Cited by 22
Murase, T., Tsuji, T., & Kajihara, Y. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.02.013 · Cited by 22
Andersen, A. D. H., Lange, M., & Lillevang, S. T. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00019.x · Cited by 22
Scanlon, S. T., & McKenzie, A. N. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12464 · Cited by 26
Costimulation: critical pathways in the immunologic regulation of asthma
Bellou, A., & Finn, P. W. (2005) · Current Allergy and Asthma Reports · doi:10.1007/s11882-005-0089-6 · Cited by 24
Pedros, C., Altman, A., & Kong, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02412 · Cited by 22
O’Brien, C. A., Batista, S. J., Still, K. M., & Harris, T. H. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801229 · Cited by 23
“ICOS is a costimulatory molecule expressed on activated T cells (22, 23).”
BackgroundRaineri, D., Cappellano, G., Vilardo, B., Maione, F., Clemente, N., Canciani, E., Boggio, E. M., Gigliotti, C. L., Monge, C., Dianzani, C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines10010051 · Cited by 22
“Its main known function is to trigger ICOS, a costimulatory receptor expressed by activated T cells [21].”
BackgroundChevrier, S., Genton, C., MALISSEN, B., Malissen, M., & Acha‐Orbea, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00027 · Cited by 23
Kueng, H. J., Schmetterer, K. G., & Pickl, W. F. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000320224 · Cited by 22
Zhang, Q., Bagrade, L., Clarke, E., Paton, J. C., Nunez, D. A., & Finn, A. H. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/652495 · Cited by 21
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Beier, K. C., Kallinich, T., & Hamelmann, E. H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00094406 · Cited by 21
Self-citationLymphocyte tracking and interactions in secondary lymphoid organs
Millington, O. R., Zinselmeyer, B. H., Brewer, J. M., Garside, P., & Rush, C. M. (2007) · Inflammation Research · doi:10.1007/s00011-007-7017-2 · Cited by 21
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator1
Nakamura, Y., Yasunami, Y., Satoh, M., Hirakawa, E., Katsuta, H., Ono, J., Kamada, M., Todo, S., Nakayama, T., Taniguchi, M., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000063705.80764.0f · Cited by 21
CD28 and ICOS in immune regulation: Structural insights and therapeutic targeting
Upadhyay, S., Kaur, B., & Gabr, M. T. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130310 · Cited by 20
Inoue, Y., Inui, N., Karayama, M., Asada, K., Matsuura, S., Ikeda, M., Uto, T., Fujii, M., Hashimoto, D., Matsui, T., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04193-w · Cited by 20
“1 3 ICOS, the third member of the CD28 co-receptor family, is a T cell-specific co-stimulatory receptor that promotes memory and effector T cell development and T cell response to foreign antigens (Hutloff et al. 1999; Amatore et al. 2020).”
BackgroundJi, H., & Zhou, Z. (2022) · Cancers · doi:10.3390/cancers14143505 · Cited by 21
Blair, T. C., Baird, J. R., Bambina, S., Kramer, G. F., Gostissa, M., Harvey, C. J., Gough, M. J., & Crittenden, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-19256-8 · Cited by 20
The role of dendritic cells in radiation-induced immune responses
Kaur, A. P., Alice, A. F., Crittenden, M. R., & Gough, M. J. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.02.002 · Cited by 21
Atsukawa, M., Nakatsuka, K., Kobayashi, T., Shimizu, M., Tamura, H., Harimoto, H., Takahashi, H., & Sakamoto, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06882.x · Cited by 20
Marriott, C. L., Carlesso, G., Herbst, R., & Withers, D. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445421 · Cited by 20
Considering B7-CD28 as a family through sequence and structure
West, S. M., & Deng, X. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219855970 · Cited by 22
ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency
Roussel, L., & Vinh, D. C. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.03.001 · Cited by 22
Brandi, J., Lehmann, C., Kaminski, L., Wiesch, J. S. Z., Addo, M. M., Ramharter, M., Mackroth, M. S., Jacobs, T., & Riehn, M. (2021) · European Journal of Immunology · doi:10.1002/eji.202149424 · Cited by 20
“Apart from the high expression of CD44 or ICOS, which are associated with T cell activation (Hutloff et al., 1999), these clusters are characterized by immune regulatory molecules like TIM-3, CD39, TIGIT, PD-1, and LAG-3 (Fig 1B, red frame).”
BackgroundFollicular associated T cells and their B‐cell helper qualities
Haynes, N. M. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00995.x · Cited by 28
Gajewska, B., Tafuri, A., Świrski, F. K., Walker, T. D., Johnson, J. R., Shea, T., Shahinian, A., Goncharova, S. I., Mak, T. W., Stämpfli, M. R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3000 · Cited by 20
Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
Wang, H., Wei, H., Zhang, R., Hou, S., Li, B., Qian, W., Zhang, D., Kou, G., Dai, J., & Guo, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2381 · Cited by 20
Esposito, P. B., Grosjean, F., Rampino, T., Libetta, C., Gregorini, M., Fasoli, G., Marchi, G., Sileno, G., Montagna, F., & Canton, A. D. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.829470 · Cited by 22
Dissection of cytotoxic and helper T cell responses
Schepers, K., Arens, R., & Schumacher, T. N. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5266-1 · Cited by 30
Immunomodulatory Effects of Antigen-Pulsed Macrophages in a Murine Model of Allergic Asthma
Janssen, E. M., Wauben, M. H. M., Nijkamp, F. P., van Eden, W., & van Oosterhout, A. J. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.27.2.4788 · Cited by 20
Bellinghausen, I., Klostermann, B., Böttcher, I., Knop, J., & Saloga, J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01845.x · Cited by 20
Modification of accessory molecule signaling
Crow, M. K. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0018-3 · Cited by 20
T-lymphocyte coactivator molecules
Salazar‐Fontana, L. I., & Bierer, B. E. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200101000-00002 · Cited by 20
Ji, Y. R., Kim, H. J., Yu, D. H., Bae, K. B., Park, S. J., Yi, J. K., Kim, N., Park, S. J., Oh, K. B., Hwang, S. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374835 · Cited by 19
Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening
Calvo‐Barreiro, L., Talagayev, V., Pach, S., Abdel‐Rahman, S. A., Wolber, G., & Gabr, M. T. (2023) · ChemMedChem · doi:10.1002/cmdc.202300305 · Cited by 19
Geng, Q., & Jiao, P. (2024) · Molecules · doi:10.3390/molecules29020454 · Cited by 19
Discovery of ICOS‐Targeted Small Molecules Using Affinity Selection Mass Spectrometry Screening
Zhang, L., Calvo‐Barreiro, L., Batista, V. S., Świderek, K., & Gabr, M. T. (2024) · ChemMedChem · doi:10.1002/cmdc.202400545 · Cited by 19
Xiao, H., Luo, Y., Lai, X., Fu, S., Shi, J., Tan, Y., He, J., Xie, W., Zheng, W., Wang, L.-M., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.066159 · Cited by 19
Common variable immunodeficiency: a multifaceted and puzzling disorder
Bergbreiter, A., & Salzer, U. (2009) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.5.2.167 · Cited by 26
Liu, H., Zheng, T., Mao, Y., Xu, C., Wu, F., Bu, L., Mou, X., Zhou, Y., Yuan, G., Wang, S., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0631-9 · Cited by 21
Yan, J., Zhang, X., Sun, S., Yang, T., Yang, J., Wu, G., Qiu, Y., Yin, Y., & Xu, W. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000501686 · Cited by 19
Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells
Yang, L., Jing, Y., Kang, D., Jiang, P., Li, N., Zhou, X., Chen, Y., Westerberg, L. S., & Liu, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.004 · Cited by 19
Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival
Schönberg, A., Hamdorf, M., & Bock, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051280 · Cited by 19
“ICOS-ICOSL interaction plays a significant role in T cell activation and differentiation to Th1 or Th2 cells, respectively, as well as in tailoring the immune response through cytokine production [68,105,106].”
BackgroundLuff, D. H., Wojdyła, K., Oxley, D., Chessa, T. A. M., Hudson, K., Hawkins, P. T., Stephens, L., Barry, S. T., & Okkenhaug, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631271 · Cited by 19
“Based on the fact that ICOS and BCAP are upregulated in activated T cells and BCAP is not expressed at the protein level in naïve T cells [(34); Figures 3A,B], it was possible that other differences in the p110δ-interactomes were mainly due to differential expression of the interactors.”
BackgroundInfluentialLong, Y., Feng, J., Ma, Y., Sun, Y., Xu, L., Song, Y., & Liu, C. (2021) · European Journal of Immunology · doi:10.1002/eji.202049093 · Cited by 19
The role of A Disintegrin and Metalloproteinase (ADAM)-10 in T helper cell biology
Sezin, T., Selvakumar, B., & Scheffold, A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119192 · Cited by 19
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo
Shilling, R. A., Clay, B. S., Tesciuba, A. G., Berry, E. L., Lu, T. Y., Moore, T. V., Bandukwala, H. S., Tong, J., Weinstock, J. V., Flavell, R. A., et al. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.06.013 · Cited by 24
“Similar to CD28, ICOS has been shown to augment T cell proliferation, Th2 differentiation and production of IL-4 but unlike CD28, ICOS costimulation does not induce high levels of IL-2 production [2,3].”
BackgroundSuppression of T cell costimulator ICOS by Δ9-tetrahydrocannabinol
Lu, H., Kaplan, B. L. F., Ngaotepprutaram, T., & Kaminski, N. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608390 · Cited by 19
Chen, S., Zhang, Q., Shen, L., Liu, Y., Xu, F., Li, D., Fu, Z., Yuan, W., Pang, D., & Li, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048031 · Cited by 19
Kong, B. Y., Bolton, H. A., Kim, J. W., Silveira, P. A., Fromm, P. D., & Clark, G. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00050 · Cited by 22
“Inducible T-Cell Costimulator (ICOS, CD278) Inducible T-cell costimulator (ICOS) is a co-stimulatory receptor with sequence homology to CD28 (76).”
BackgroundDong, X., Song, J., Chen, B., Qi, Y., Jiang, W., Li, H., Zheng, D., Wang, Y., Zhang, X., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.592811 · Cited by 19
“BTLA is also a member of the CD28 immunoglobulin superfamily, which includes CTLA-4, CD28, inducible costimulatory molecule (ICOS), and PD-1 (18).”
BackgroundPeter, H. H., & Warnatz, K. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.s61 · Cited by 19
Pawelec, G. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00209-8 · Cited by 21
Nabeyama, K., Yasunami, Y., Toyofuku, A., Nakano, M., Satoh, M., Matsuoka, N., Ono, J., Kamada, M., Uede, T., Todo, S., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000144054.46946.cf · Cited by 19
Reshaping the past: Strategies for modulating T-cell memory immune responses
Ndejembi, M. P., Tang, A. L., & Färber, D. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.012 · Cited by 19
Effects of the new immunosuppressive agent AEB071 on human immune cells
Matz, M., Weber, U., Mashreghi, M., Lorkowski, C., Ladhoff, J., Kramer, S., Neumayer, H., & Budde, K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp775 · Cited by 18
The PD-1/PD-L1 pathway and Epstein–Barr virus
Wang, H., Zhang, N., Xu, R., Ji, C., Wei, Y., Liu, Z., & Mi, Q. S. (2025) · European journal of medical research · doi:10.1186/s40001-025-02694-1 · Cited by 20
“Studies have shown that the latent EBV gene expression program mirrors that observed in malignancies linked to EBV, suggesting that immune regulation is a critical factor in preventing these latent programs from transforming into lymphomas [102, 103].”
Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4+ T Cells
Techasintana, P., Davis, J. W., Gubin, M. M., Magee, J., & Atasoy, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129321 · Cited by 19
Adaptive resistance: A tumor strategy to evade immune attack
Yao, S., & Chen, L. (2013) · European Journal of Immunology · doi:10.1002/eji.201243275 · Cited by 21
Molecular Dynamics of Co-signal Molecules in T-Cell Activation
Saito, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_5 · Cited by 18
ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study
Xu, F., Li, D., Zhang, Q., Fu, Z., Zhang, J., Yuan, W., Chen, S., 庞达, & Li, D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-392 · Cited by 18
Therapeutic potential of immunostimulatory monoclonal antibodies
Gray, J. C., Johnson, P., & Glennie, M. J. (2006) · Clinical Science · doi:10.1042/cs20060024 · Cited by 18
Characterization of B7S3 as a Novel Negative Regulator of T Cells
Yang, Y., Liu, X. K., Nguyen, T. D., Bishop, C., Graf, D., & Dong, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3661 · Cited by 18
Nukada, Y., Okamoto, N., Konakahara, S., Tezuka, K., Ohashi, K., Mizuno, K., & Tsuji, T. (2006) · International Immunology · doi:10.1093/intimm/dxl115 · Cited by 18
Modulation of costimulation to enhance tumor immunity
Vesosky, B., & Hurwitz, A. A. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0424-5 · Cited by 22
T-Cell Costimulatory Blockade in Organ Transplantation
Maltzman, J. S., & Turka, L. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015537 · Cited by 20
Wyatt, M. M., Huff, L. W., Nelson, M. H., Neal, L. R., Medvec, A. R., Rivera, G. O. R., Smith, A. S., Rivera-Reyes, A. M., Knochelmann, H. M., Riley, J. L., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.04.010 · Cited by 17
Hilton, J. F., Ott, P. A., Hansen, A. R., Li, Z., Mathew, M., Messina, C. H., Dave, V., Ji, X., Karpinich, N. O., Hirschfeld, S., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03623-z · Cited by 17
“Inducible T-cell co-stimulator (ICOS) is a co-stimulatory receptor highly expressed in tumor-infiltrating lymphocytes in many cancer types [8, 9].”
BackgroundArjunaraja, S., Massari, P., Wetzler, L. M., Lees, A., Colino, J., & Snapper, C. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101446 · Cited by 19
Lavini‐Ramos, C., Silva, H. M., Schanoski, A. S., Monteiro, S. M., Ferreira, L. R. P., Pacanaro, A. P., Gomes, S. A., Batista, J., Fae, K. C., Kalil, J. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00923-0 · Cited by 17
Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity
Solé, P., & Santamaría, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684240 · Cited by 17
Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus
Stefanski, A., & Dörner, T. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000825 · Cited by 21
Imaging and therapeutic targeting of the tumor immune microenvironment with biologics
Arnouk, S. M., Groof, T. W. M. D., & Ginderachter, J. A. V. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114239 · Cited by 17
Alves, G. F., Stoppa, I., Aimaretti, E., Monge, C., Mastrocola, R., Porchietto, E., Einaudi, G., Collotta, D., Bertocchi, I., Boggio, E. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992614 · Cited by 17
“It is a type I transmembrane glycoprotein whose expression is rapidly upregulated upon T cells activation (3).”
BackgroundYadavilli, S., Waight, J. D., Brett, S. J., Bi, M., Zhang, T., Liu, Y.-B., Ellis, C. E., Turner, D. C., Hahn, A., Shi, H., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0293 · Cited by 17
Tajima, N., Tezuka, K., Tanimoto, A., Miyai, A., Tanimoto, M., Maruhashi, J., & Watanabe, Y. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.06.004 · Cited by 17
“Activation–inducible lymphocyte immunomediatory molecule (AILIM)/inducible costimulator (ICOS), the third identified member of the CD28 family, plays a unique role in T–cell function [3–5].”
BackgroundNie, X., Cai, G., Zhang, W., Wang, H., Wu, B., Li, Q., & Shen, Q. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.11.001 · Cited by 17
Role of inducible costimulator in the development of lupus in MRL/lpr mice
Tada, Y., Koarada, S., Tomiyoshi, Y., Morito, F., Mitamura, M., Haruta, Y., Ohta, A., & Nagasawa, K. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.02.009 · Cited by 17
Deppong, C. M., Parulekar, A. D., Boomer, J. S., Bricker, T. L., & Green, J. M. (2010) · European Journal of Immunology · doi:10.1002/eji.200940282 · Cited by 17
Toldi, G., Vásárhelyi, B., Biró, E., Fügedi, G., Rigó, J. J., & Molvarec, A. (2013) · American Journal of Reproductive Immunology · doi:10.1111/aji.12069 · Cited by 17
Recent advances and current state of immunotherapy in systemic lupus erythematosus
Mok, M. Y., & Shoenfeld, Y. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1171840 · Cited by 18
VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege
Kunishige, T., Taniguchi, H., Ohno, T., Azuma, M., & Hori, J. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27322 · Cited by 17
Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)
Acosta‐Ampudia, Y., Zafra, M. P., Ojeda, G., Bernardone, I. S., Dianzani, U., Portolés, P., & Rojo, J. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0606-1 · Cited by 18
Wiendl, H., Neuhaus, O., Mehling, M., Wintterle, S., Schreiner, B., Mitsdoerffer, M., Wienhold, W., Weissert, R., Wessels, J., Hartung, H.-P., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00172-3 · Cited by 17
“ICOS is induced and upregulated after T cell activation and binds to ICOSL, a member of the B7 family ligands (Beier et al., 2000; Hutloff et al., 1999; Yoshinaga et al., 1999).”
BackgroundMethodYamaguchi, N., Hiraoka, S.-I., Mukai, T., Takeuchi, N., Zhou, X., Ono, S., Kogo, M., Dunussi‐Joannopoulos, K., Ling, V., Wolf, S. F., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1347 · Cited by 17
It takes more than two to tango
Schwartz, R. H. (2001) · Nature · doi:10.1038/35051202 · Cited by 17
Fabián, D., Gong, N., Vogt, K., Volk, H., Pleyer, U., & Ritter, T. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0629-y · Cited by 18
Kallinich, T., Beier, K. C., Gelfand, E. W., Kroczek, R. A., & Hamelmann, E. H. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02369.x · Cited by 22
Self-citationICOS/B7RP-1 Interference in Mouse Kidney Transplantation
Lutz, J., Lu, R., Strobl, M., Huang, H. X., Deng, M., Wang, M., Ouyang, N., & Heemann, U. W. (2007) · Transplantation · doi:10.1097/01.tp.0000267439.15439.61 · Cited by 17
Salzer, U., & Grimbacher, B. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231906.12172.6e · Cited by 18
Boggio, E. M., Gigliotti, C. L., Moia, R., Scotta, A. M., Crespi, I., Boggione, P., Paoli, L. D., Deambrogi, C., Garzaro, M., Vidali, M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17968 · Cited by 17
MiR-155 -targeted IcosL controls tumor rejection
Tili, E., Otsu, H., Commisso, T. L., Palamarchuk, A., Balatti, V., Michaille, J., Nuovo, G. J., & Croce, C. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408649121 · Cited by 16
“ICOSL acts as the ligand for ICOS/ CD278, a T cell–specific surface costimulatory molecule structurally related to CD28 and CTLA - 4 (17).”
A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
Missailidis, D., Ebrahimie, E., Dehcheshmeh, M. M., Allan, C. Y., Sanislav, O., Fisher, P., Gras, S., & Annesley, S. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450853 · Cited by 16
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.